An interview with Stewart Frost, of J P Morgan Private Bank, on the outlook from investors.
The companies aim to create a global powerhouse in DNA damage repair space.
The AI-powereed system has been shown to be more than 90 per cent accurate.
The Cambridge Science Park company is using unique technology to target brain diseases.
The agreement reduces potential milestone payments, but expedite its development.
Gurdon Institute work could prove key to developing new drugs against SARS-CoV-2.
The company has also announced a number of approvals.
The shortlist of companies and individuals across 14 categories has been unveiled.
The funding will help it expand its product portfolio and reach more health systems.
From biotechs to AI companies, cleantechs to start-ups, an astonishing array of talent is on show.
The board of the Waterbeach-based cell engineering specialist say the company is ready for a US listing.
When the R&D Centre opens, the courtyard will be open to the public.
Director Adam Nethersole discusses how the pandemic has highlighted the importance of HPC for the sector.
The new partnership will enable new cell therapies and even accelerate prototype organ printing.
